Companion Diagnostics Co-developmentA Guide for Diagnostics Companies


USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

This service provides state-of-the-industry insights for companion diagnostic co-development partnerships between drug companies and their diagnostic partners. Topics include drivers for companion diagnostic programs, a comparison of co-development business models, a guide for what drug companies look for in companion diagnostic partners, and an outline of the various opportunities for servicing pharmaceutical clients. Final recommendations are given for how to compete in a market that will be impacted by the changing trends of in vitro diagnostics, reimbursements, and regulatory oversights.

Table of Contents

Companion Diagnostics Co-development—A Guide for Diagnostics CompaniesAnalysis of Drug-companion Diagnostics Co-development PartnershipsCompanion Diagnostics

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.